Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,967.38
(
0.00%
)
US TECH 100
25,120.00
(
-0.10%
)
Dow Jones
48,535.99
(
0.00%
)
Brent Oil
93.06
(
-2.52%
)
Bitcoin
74,414.21
(
0.29%
)
News Focus
News Focus
Post# of 517277
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rayovacAAA

Send PM Follow Ignore
Followers 16
Posts 5838
Boards Moderated 0
Alias Born 07/16/2018

rayovacAAA

Re: Lima4918 post# 246948

Sunday, 04/19/2020 3:53:05 PM

Sunday, April 19, 2020 3:53:05 PM

Post# of 517277
YET HAMPEL LEFT THE AVXL TEAM AND WENT TO EISAI!!!!!!!!


Eisai installs new Alzheimer's clinical trial leadership team

Eisai unveiled the transfer of Irizarry to the new role alongside news of the appointment of Harald Hampel as VP, global medical affairs, Alzheimer's. The appointment puts Hampel in charge of coming up with Eisai’s global medical strategies in Alzheimer's and dementia. And he'll oversee phase 3b and 4 clinical trials of Alzheimer’s drugs, if one makes it that far.




GOOD LUCK AND GOD BLESS!!!!!!!!!!
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News